Plasma: The Fourth State of Matter
Novaerus uses a patented atmospheric plasma discharge of the dielectric barrier discharge type. The plasma discharge comprises electrons and ions that cause extensive damage to microorganisms. Unlike other products, microorganisms are exposed directly to the plasma discharge as opposed to by-products of the discharge.
Novaerus plasma is powerful, yet gentle. With no harmful byproducts, it is safe for use around children, the elderly, and the sick. Novaerus portable units are simple to use, low-maintenance and highly effective for rapid or continuous infection control, odour mitigation, and particle reduction.
Under the Microscope
“The bacteria underwent physical distortion to varying degrees, resulting in deformation of the bacterial structure. The bacterial reculture experiments confirm inactivation of airborne E. coli upon treating with DBD.”
NASA Ames Research Center
Healthy E. coli Bacteria (prior to exposure)
E.coli Bacteria (Destroyed by Novaerus Plasma after 0.002 seconds)
Novaerus ultra-low energy plasma technology shown to destroy E.coli bacteria on contact.
Remove Airborne Pathogens & Pollutants in Intensive Care Units
ICU and oncology patients are at heightened risk for healthcare-acquired infections due to the severity of their illness. ICU patients typically have a compromised immune system, long length of hospital stay, several caregivers performing multiple tasks, and a high quantity of invasive devices being used. All of these factors contribute to a greater potential for contact with biological or environmental contamination.
How Novaerus Compares
Compare Novaerus with other air purification technologies.
(1 = Not Effective 5 = Very Effective)
Tested & Proven
Novaerus technology has been shown to be safe and effective in dozens of laboratory tests, case studies, and clinical trials conducted around the world.
Clostridium difficile Spore Reduction
Novaerus Defend 1050 was shown to reduce 99.6% of airborne C. difficile within the first 20 minutes of operation and >99.9% after 40 minutes.
TAGS: AIRMID, IRELAND, NV1050, BACTERIA
Mycobacterium tuberculosis Bacteria Reduction
Novaerus Defend 1050 was shown to reduce the concentration of M. smegmatis (surrogate for M. tuberculosis) by 97% after 30 minutes of operation.
TAGS: NV1050, TB, AIRMID, BACTERIA, TB
Novaerus Protect 800/900 was shown to reduce formaldehyde by 85% during a 14-hour testing experiment.
TAGS: NV800/900, AVOMEEN, VOC, MICHIGAN, US, VOC
Influenza A Reduction
Novaerus Defend 1050 was shown to reduce 99.9% of airborne Influenza A within the first 10-20 minutes of operation.
TAGS: AIRMID, IRELAND, NV1050, VIRUS
Novaerus Defend 1050 removed 99% of PM2.5 within 6.26 minutes and 99% of PM1.0 within 6.33 minutes.
TAGS: NV1050, CAMFIL, PARTICLES, SWEDEN
Staphylococcus epidermidis Bacteria Reduction
Novaerus Defend 1050 achieved a microbial cell reduction of 99.94% of Staphylococcus epidermidis within 15 minutes of operation.
TAGS: NV1050, BACTERIA, MRSA, IRELAND
Airborne Allergen Reduction
Novaerus Protect 800/900 was shown to reduce overall allergens by 41.16%, including house dust mites, feline dander, canine dander, and pollen.
TAGS: NV800/900, INDOOR BIOTECHNOLOGIES, WALES, UK, ALLERGIES
Methicillin-resistant Staphylococcus aureus (MRSA) Reduction
Novaerus Protect 800/900 reduced 99.99% of methicillin-resistant Staphylococcus aureus (MRSA) bacteria over the course of four hours.
TAGS: NV800, NV900, MICROBAC, NORTH CAROLINA, US, BACTERIA
Significant impact at long term care facility
Comparison of nosocomial infection rates for the June to September period, 2012 vs. 2013
RB Health Partners, Inc., December 3, 2013
Every floor at long term care facility improved
Comparison of nosocomial infection rates
RB Health Partners, Inc., May 2015
Novaerus portable deployment against influenza
- MS2 virus – surrogate for influenza and Norovirus
- Results: 4.4 log (> 99.99%) reduction
- Test Lab: Aerosol Research and Engineering labs (ARE Labs, Olathe, Kansas)
- Reception Desk
- Supply Rooms
- Patient Bedside
- School Buses
- Create a healthy environment with air purification
- Reduce patient readmissions rates
- Keep your staff healthy
- Maintain an excellent referral status with hospitals
Health Center of Hopkinsville, Kentucky
“We have shown a reduction in upper respiratory infections by 60% over past years’ numbers. We have reduced the number of isolation days for C-diff patients by 20% on average and feel that this occurs because of reduction in airborne cells. We have not had a norovirus outbreak this year or flu, even though both are in the community. Christian”
RB HEALTH PARTNERS, INC. FLORIDA, US
“Clearly, implementation of the Novaerus technology has contributed significantly to the infection control as well as quality improvement efforts.”
Specialised Hospital, Chorzów, Poland
“Results of microbiological tests of the air in the areas where the devices were installed revealed significant reduction in the number of microorganisms. Moreover, permanent elimination of unwanted odours in the tested rooms was noted. The devices tested in our facility deserve to be widely used in healthcare institutions, and particularly in sites of high epidemiological risk.”
Hospital of Infectious and Tropical Diseases “Dr. Victor Babes,” Bucharest, Romania
“In the case of the air samples collected during the period of operation of the system, the number of colony-forming units was up to 96% lower than in the case of air samples collected before the system started to be used for strains of both bacteria and fungi. The hospital staff found the Novaerus air purification system to be: tolerable, easy to use and safe for patients and staff. The Novaerus air purification system complements existing measures to combat infections and does not require additional interventions to ensure that it functions without interruption.”
Korea Medical Hub, H-Cube Neonatal Centre
“Not a single infection occurred after the installation of the Novaerus devices. Novaerus helped to reassure mothers over safety concerns and contributed to increased revenue by differentiating us from other hospitals that don’t offer the technology. Furthermore, during the periodical test by the Public Health Inspectors for air quality, Novaerus exceeded our expectations and we managed to get approval without any problem.”
Uzsoki Hospital, Budapest, Hungary
“Since Novaerus airborne infection control technology has been installed in our department – comparing to previous years’ trends – there have been no outbreaks (MRSA, Clostridium difficile, Influenza) and the air quality has generally improved; bad odour formerly detected from time-to-time in the wards and permanently in the laundry storage area has been completely eliminated by now.”
Leopardstown Park Hospital, Dublin, Ireland
“We ended up with clinical and financial benefits beyond our expectations. We haven’t had a single influenza outbreak in a year, and staff sick leave is down by 45% year-on-year. I can’t recommend Novaerus highly enough.”
Pflegeresidenz Haus der Ruhe (Retirement Home), Garbsen, Germany
“We have tested the Novaerus devices thoroughly and we are now absolutely convinced by their positive impact. We are about to install them everywhere in our facility to protect our patients, their families and our staff from dangerous infections – in particular Norovirus and MRSA – as well as strong odours.”
University of Szeged, Hungary
The operation of the machines has clearly improved air quality, significantly decreasing and eliminating the unpleasant smells that were present previously. The noise emitted by the equipment is insignificant, it does not disturb the patients. The [test] results reveal that apart from reducing the quantity of organic molecules causing the smells, the equipment also significantly decreased the quantity of pathogenic organisms.
Linde Healthcare, Vienna, Austria
After one winter’s use of Novaerus’ products, our employee sick time was reduced by 40% and improved the office’s indoor air quality. In addition to the health improvements noted, employees noticed the office was fresh and lacked its previous winter season staleness.